MOUNTAIN VIEW, Calif. – Caliper Technologies Corp., a microchip laboratory company, went public December 15, offering 4.5 million shares at $16 apiece. The company’s stock priced above its $13 to $15 filing range.
There were no selling shareholders. Venture backers included Venrock Associates, Lombard Odier & Cie, CW Group, The Dow Chemical Co., Hoffman LaRoche Inc., ARCH Venture Partners and BB BioVentures LP.
The company produces LabChip microchips that contain a network of channels through which fluids and chemicals are manipulated to perform various experiments and tests.
The $66 million in proceeds expected from the IPO will be used for general corporate purposes, including capital expenditures, and research and development.
Caliper has never been profitable, losing $6.3 million in 1997 and $3 million in 1998.
Robert Nelsen, a managing director at ARCH, joined the board in September 1995. Anthony Evnin, a general partner at Venrock, joined the company’s board of directors in June 1996, together with Charles Hartman, a general partner at CW Group.
Caliper Technologies – Selected Financial
(in thousands, except per share data)
July 26, 1995 (inception) Year Ended December 31 Nine Months Ended September 30
to December 31, 1995 1996 1997 1998 1998* 1999*
Total revenue 132 2,266 8,155 4,425 8,859
Net loss -536 -4,710 -6,281 -2,975 -3,745 -8,126
Net loss per share -1.71 -3.9 -4.38 -2.39 -2.54 -3.71